254. Porphyria Clinical trials / Disease details
Clinical trials : 70 / Drugs : 54 - (DrugBank : 19) / Drug target genes : 19 - Drug target pathways : 35
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01573754 (ClinicalTrials.gov) | March 21, 2006 | 5/4/2012 | Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda | A Prospective Comparison of Low Dose Hydroxychloroquine and Phlebotomy in the Treatment of Porphyria Cutanea Tarda. IRB 02-435 | Porphyria Cutanea Tarda | Drug: Hydroxychloroquine;Procedure: Phlebotomy | The University of Texas Medical Branch, Galveston | NULL | Active, not recruiting | 18 Years | 100 Years | All | 100 | Phase 2 | United States |